Disease areas
Cardiology
Mapping prevention, diagnostics and access pathways for cardiovascular care.
Cardiometabolic
Tracking risk, prevention and access in metabolic and vascular health.
Eye Disease
Following diagnostics, treatment access and equity in vision care.
Infectious disease
Tracking diagnostics, resistance, prevention and access across infection pathways.
Neurology
Mapping early diagnosis, biomarkers and access in brain health.
Oncology
Following testing, treatment access and equity across cancer pathways.
Cardiology
See all →
Lifelong exercise protects the heart. It can also make the heart harder to read
Exercise is already medicine. Cardiology wants doctors to prescribe it that way
Clinicians are already asking AI what to do, not just what the diagnosis is
Severe preeclampsia may leave a measurable signature in the fetal heart
Europe is building the infrastructure to decide which cardiovascular AI can be trusted
Why rural cardiology needs more than another recruitment drive
The protein boom has a cardiology blind spot
Not everyone needs a cardiologist. Everyone needs cardiovascular risk assessment
Low magnesium may be more than a lab abnormality in emergency care
Europe wants to catch cardiovascular risk before the first event
Cardiometabolic
See all →
If BMI misses cardiovascular risk, why is policy still built around it?
Low testosterone in young men may be a metabolic warning sign, not a treatment target
AstraZeneca’s potential $1.5B insitro deal puts AI on the hardest question in cardiometabolic R&D
Fasted cardio burns more fat during exercise, but the long-term advantage disappears
Tirzepatide’s Next Question: What Lies Beyond Cardiovascular Events?
The gut microbiome is entering rehabilitation medicine. The evidence is not ready for routine care
Survodutide’s Phase III data raise a bigger question than weight loss
Life insurers are moving from pricing metabolic risk to trying to reduce it
Heart-healthy eating is becoming a health-system issue, not just a patient choice
As GLP-1 use scales, dermatology is becoming part of obesity care
Eye Disease
See all →
Singapore wants healthcare AI that does not think like the West. Cardiometabolic care is its first real test
El Salvador Eliminated Trachoma. The Certificate Is Not The Finish Line.
The Most Preventable Cause of Vision Loss May Still Be Smoking
Cellular Reprogramming Enters Neuro-Ophthalmology
Not All Eye Infections Are Equal: New Evidence Points to a Precision Medicine Approach
The Air We Breathe May Be Shaping the Future Burden of Blindness
Ozempic and Eye Health: Balancing Metabolic Benefits with Vision Risks
Diabetic Eye Screening Is Becoming Risk-Based
Abu Dhabi Puts Rare Eye Gene Therapy on the Regional Map
AI Eye Screening Has an Image Quality Problem
Infectious disease
See all →
Neurology
See all →
Ten Years of MS Data Make Delay Harder to Defend
Schizophrenia Gets a Five-Day Brain-Stimulation Signal
Genomics Is Becoming an Acute Neurology Test
Epilepsy Treatment Does Not Have to End Breastfeeding
Alzheimer’s Blood Tests Are Changing Decisions, Not Just Diagnoses
Adolescent Mental Health Has a Movement Problem
Stroke Is Getting Younger While Prevention Stays Old
Schizophrenia’s Missing Symptoms Move Onto the Phone
Parkinson’s Is Trying to Vaccinate Against Progression
MOGAD May Finally Have a Clue to Who Relapses
Oncology
See all →
One Blood Test for 50 Cancers Is Closer to the FDA. The Evidence Is Still Fighting Back.
Skin Cancer AI Has Crossed a Line: It Is Discharging Patients on Its Own
Precision Oncology Has a Scale Problem
One in Eight Cancers Starts With an Infection
ESR1 Resistance Is Becoming a Treatment Pathway, Not a Footnote
CLL Just Moved a Noncovalent BTK Inhibitor Into First Line
Myeloma Pain May Need 4 Gy, Not a Treatment Odyssey
Kidney Cancer Has a New Post-Immunotherapy Standard. Survival Is Not Settled.
Kidney Cancer Has a New Post-Immunotherapy Standard. Survival Is Not Settled.
